Metabolic syndrome in peritoneal dialysis patients: Choice of diagnostic criteria and prognostic implications

Clinical Journal of the American Society of Nephrology

Volumn 9, Issue 4, 2014, Pages 779-787

  Szeto, Cheuk Chun ^a   Kwan, Bonnie Ching Ha ^a   Chow, Kai Ming ^a   Leung, Chi Bon ^a   Cheng, Mei Shan ^a   Law, Man Ching ^a   Li, Philip Kam Tao ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; CARDIOVASCULAR RISK; COMORBIDITY; DYSGLYCEMIA; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROALBUMINURIA; OBESITY; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; PREVALENCE; PULSE WAVE; AGED; ARTERIAL STIFFNESS; COMPARATIVE STUDY; EPIDEMIOLOGY; HONG KONG; KIDNEY FAILURE, CHRONIC; LENGTH OF STAY; MIDDLE AGED; MORTALITY; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT OUTCOME;

ADIPOSITY; ADULT; AGED; FEMALE; HONG KONG; HUMANS; KIDNEY FAILURE, CHRONIC; LENGTH OF STAY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NUTRITIONAL STATUS; PERITONEAL DIALYSIS; PREDICTIVE VALUE OF TESTS; PREVALENCE; PULSE WAVE ANALYSIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR STIFFNESS;

EID: 84922325973     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06620613     Document Type: Article

References (36)

1. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group: The metabolic syndrome—a new worldwide definition. Lancet 366: 1059–1062, 2005.
2. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288: 2709–2716, 2002.
3. Singh AK, Kari JA: Metabolic syndrome and chronic kidney disease. Curr Opin Nephrol Hypertens 22: 198–203, 2013.
4. Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD: Metabolic syndrome and kidney disease: A systematic review and meta-analysis. Clin J Am Soc Nephrol 6: 2364–2373, 2011.
5. Tanaka H, Shiohira Y, Uezu Y, Higa A, Iseki K: Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int 69: 369–374, 2006.
6. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J: The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140: 167–174, 2004.
7. Shahrokh S, Heydarian P, Ahmadi F, Saddadi F, Razeghi E: Association of inflammatory biomarkers with metabolic syndrome in hemodialysis patients. Ren Fail34: 1109-1113, 2012.
8. Yang SY, Chiang CK, Hsu SP, Peng YS, Pai MF, Ho TI, Hung KY, Wu KD: Metabolic syndrome predicts hospitalization in hemodialysis patients: A prospective Asian cohort study. Blood Purif 25: 252-259, 2007.
9. Jiang N, Qian J, Lin A, Lindholm B, Axelsson J, Yao Q: Initiation of glucose-based peritoneal dialysis is associated with increased prevalence of metabolic syndrome in non-diabetic patients with end-stage renal disease. Blood Purif 26: 423-428, 2008.
10. Johnson DW, Armstrong K, Campbell SB, Mudge DW, Hawley CM, Coombes JS, Prins JB, Isbel NM: Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification. Nephrology (Carlton) 12:391-398, 2007.
11. Chen HY, Kao TW, Huang JW, Chu TS, Wu KD: Correlation of metabolic syndrome with residual renal function, solute transport rate and peritoneal solute clearance in chronic peritoneal dialysis patients. Blood Purif 26: 138-144, 2008.
12. Zhe XW, Zeng J, Tian XK, Chen W, Gu Y, Cheng LT, Chen HM, Axelsson J, Lindholm B, Wang T: Pulse wave velocity is associated with metabolic syndrome components in CAPD patients. AmJ Nephrol28: 641-646, 2008.
13. Park JT, Chang TI, Kim DK, Lee JE, Choi HY, Kim HW, Chang JH, Park SY, Kim E, Yoo TH, Han DS, Kang SW: Metabolic syndrome predicts mortality in non-diabetic patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 25: 599-604, 2010.
14. Liao CT, Kao TW, Chou YH, Wu MS, Chen YM, Chuang HF, Hung KY, Chu TS, Wu KD, Tsai TJ: Associations of metabolic syndrome and its components with cardiovascular outcomes among non-diabetic patients undergoing maintenance peritoneal dialysis. Nephrol Dial Transplant26: 4047-4054, 2011.
15. Rasic S, Hadzovic-Dzuvo A, Rebic D, Uncanin S, Hadzic A, Mujakovic A, Kulenovic I: The metabolic syndrome in patients on peritoneal dialysis: Prevalence and influence on cardiovascular morbidity. BosnJ Basic MedSci 10[Suppl 1]: S3-S7, 2010.
16. Park SH, Lindholm B: Definition of metabolic syndrome in peritoneal dialysis. Perit Dial Int 29[Suppl 2]: S137-S144, 2009.
17. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539-553, 1998.
18. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285: 2486-2497, 2001.
19. Li PK, Kwan BC, Ko GT, Chow KM, Leung CB, Szeto CC: Treatment of metabolic syndrome in peritoneal dialysis patients. Perit Dial Int29[Suppl 2]: S149-S152, 2009.
20. Beddhu S, Zeidel ML, Saul M, Seddon P, Samore MH, Stoddard GJ, Bruns FJ: The effects of comorbid conditions on the outcomes of patients undergoing peritoneal dialysis. AmJ Med112: 696-701, 2002.
21. Enia G, Sicuso C, Alati G, Zoccali C: Subjective global assessment of nutrition in dialysis patients. Nephrol Dial Transplant8: 1094-1098, 1993.
22. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH: A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. AmJKidney Dis 38: 1251-1263, 2001.
23. Bergström J, Heimbürger O, Lindholm B: Calculation of the protein equivalent of total nitrogen appearance from urea appearance. Which formulas should be used? Perit Dial Int 18: 467–473, 1998.
24. Kahn R, Buse J, Ferrannini E, Stern M; American Diabetes Association; European Association for the Study of Diabetes: The metabolic syndrome: time for a critical appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28: 2289– 2304, 2005.
25. Li PK, Kwan BC, Szeto CC, Ko GT: Metabolic syndrome in peritoneal dialysis patients. Clin Kidney J 4: 206–214, 2008.
26. Kwan BC, Szeto CC, Chow KM, Law MC, Cheng MS, Leung CB, Pang WF, Kwong VW, Li PK: Bioimpedance spectroscopy for the detection of fluid verload in Chinese peritoneal dialysis patients. Perit Dial Int, in press.
27. Gao N, Kwan BC, Chow KM, Chung KY, Pang WF, Leung CB, Li PK, Szeto CC: Arterial pulse wave velocity and peritoneal transport characteristics independently predict hospitalization in Chinese peritoneal dialysis patients. Perit Dial Int 30: 80–85, 2010.
28. Hansen BC: The metabolic syndrome X. Ann N Y Acad Sci 892: 1–24, 1999.
29. Beddhu S, Pappas LM, Ramkumar N, Samore M: Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol 14: 2366–2372, 2003.
30. Port FK, Ashby VB, Dhingra RK, Roys EC, Wolfe RA: Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 13: 1061–1066, 2002.
31. Abbott KC, Glanton CW, Trespalacios FC, Oliver DK, Ortiz MI, Agodoa LY, Cruess DF, Kimmel PL: Body mass index, dialysis modality, and survival: Analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study. Kidney Int 65: 597–605, 2004.
32. Sattar N, McConnachie A, Shaper AG, Blauw GJ, Buckley BM, de Craen AJ, Ford I, Forouhi NG, Freeman DJ, Jukema JW, Lennon L, Macfarlane PW, Murphy MB, Packard CJ, Stott DJ, Westendorp RG, Whincup PH, Shepherd J, Wannamethee SG: Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet 371: 1927–1935, 2008.
33. Stern MP, Williams K, González-Villalpando C, Hunt KJ, Haffner SM: Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 27: 2676–2681, 2004.
34. Raimundo M, Lopes JA. Metabolic syndrome, chronic kidney disease, and cardiovascular disease: A dynamic and life-threatening triad. Cardiol Res Pract 2011; 2011: 747861..
35. Yu M, Ryu DR, Kim SJ, Choi KB, Kang DH: Clinical implication of metabolic syndrome on chronic kidney disease depends on gender and menopausal status: Results from the Korean National Health and Nutrition Examination Survey. Nephrol Dial Transplant 25: 469–477, 2010.
36. Szeto CC, Wong TY, Chow KM, Leung CB, Li PK: Oral sodium bicarbonate for the treatment of metabolic acidosis in peritoneal dialysis patients: A randomized placebo-control trial. J Am Soc Nephrol 14: 2119–2126, 2003.